IL6 and diabetes mellitus: Although IL-6 levels showed no significant difference (P = 0.256), fractalkine (CX3CL1) was significantly elevated in the diabetic group (4.60 ± 2.39 vs. 1.77 ± 0.94, P = 0.001), indicating critical metabolic imbalances associated with diabetes.